VPS4B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.61009983123961E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.09059983266491E-10 |
Normal-vs-Stage2 |
3.69930000000407E-05 |
Normal-vs-Stage3 |
5.448900E-04 |
Normal-vs-Stage4 |
1.70510000008228E-07 |
Stage1-vs-Stage2 |
3.151000E-01 |
Stage1-vs-Stage3 |
6.132400E-01 |
Stage1-vs-Stage4 |
3.365200E-01 |
Stage2-vs-Stage3 |
7.901400E-01 |
Stage2-vs-Stage4 |
6.715800E-02 |
Stage3-vs-Stage4 |
2.452800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.10869979863537E-10 |
Normal-vs-AfricanAmerican |
1.18270000015741E-07 |
Normal-vs-Asian |
4.22970000000245E-05 |
Caucasian-vs-AfricanAmerican |
8.497800E-01 |
Caucasian-vs-Asian |
5.459000E-01 |
AfricanAmerican-vs-Asian |
4.766400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.60247379202383E-12 |
Normal-vs-Female |
1.864000E-03 |
Male-vs-Female |
2.640800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.71979999999505E-06 |
Normal-vs-Extreme_Weight |
2.05946371067967E-12 |
Normal-vs-Obese |
6.75350000034491E-07 |
Normal-vs-Extreme_Obese |
1.317750E-02 |
Normal_Weight-vs-Extreme_Weight |
1.504580E-01 |
Normal_Weight-vs-Obese |
6.477200E-01 |
Normal_Weight-vs-Extreme_Obese |
9.531000E-01 |
Extreme_Weight-vs-Obese |
2.819700E-02 |
Extreme_Weight-vs-Extreme_Obese |
4.289400E-01 |
Obese-vs-Extreme_Obese |
7.336600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.14999999999366E-05 |
Normal-vs-Age(41-60Yrs) |
6.91160000343416E-08 |
Normal-vs-Age(61-80Yrs) |
2.14209761040252E-11 |
Normal-vs-Age(81-100Yrs) |
5.50710000046806E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.201600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.977350E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.473200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.056950E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.495800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.428800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
6.14330808446084E-12 |
Normal-VS-Type2 PRCC |
6.12340000039069E-07 |
Normal-VS-KIRP CIMP |
1.014130E-02 |
Normal-VS-Unclassified PRCC |
8.564400E-03 |
Type1 PRCC-VS-Type2 PRCC |
3.355600E-01 |
Type1 PRCC-VS-KIRP CIMP |
1.160430E-01 |
Type1 PRCC-VS-Unclassified PRCC |
1.220440E-01 |
Type2 PRCC-VS-KIRP CIMP |
4.077800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
3.867200E-01 |
KIRP CIMP-VS-Unclassified PRCC |
7.641200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.15209985785248E-10 |
Normal-vs-N1 |
1.73809999999275E-05 |
Normal-vs-N2 |
4.05410000000606E-05 |
N0-vs-N1 |
6.011400E-01 |
N0-vs-N2 |
4.333800E-01 |
N1-vs-N2 |
3.053400E-01 |
|
|